Rolvedon
Active substance: eflapegrastim
INJECTION, SOLUTION · EFLAPEGRASTIM 13.2 mg/.6mL
United StatesActive
Marketing holder: Assertio Specialty Pharmaceuticals, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- EFLAPEGRASTIM · 13.2 mg/.6mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-cfd2-7a8f-9848-ffd04814ae50,01a12097-6516-7646-affd-81327fd61a96;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 82497-132
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 82497-132 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 82497-132 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 82497-132 · Verified 2026-10-09 · open in source